unknown
Stage
About
Ensho Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule therapies targeting α4β7 integrin for the treatment of inflammatory bowel disease.
Explore Ensho Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.